REGEN
Get REGENGet Now
LibraryToolsNotesBlogFAQ

VIP (Vasoactive Intestinal Peptide) Side Effects and Safety

Reported VIP (Vasoactive Intestinal Peptide) side effects, contraindications, and safety signals.

RE
Compiled from published research · Continuously updated

Vasodilation-Related Effects

Given its potent vasodilator mechanism, the main theoretical concern is transient hypotension or flushing, particularly with systemic (subcutaneous) administration. Formal adverse-event data at research-community dosing levels is limited. Pregnancy and active malignancy are treated as precautionary contraindications given the broad immunomodulatory mechanism.

Contraindications

  • pregnancy
  • hypotension
  • active malignancy

References

  1. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects
All VIP (Vasoactive Intestinal Peptide) sections

Thymosin Alpha-1

longevity & healthspanAgrade

A 28-amino-acid thymic peptide approved in 35+ countries as Zadaxin for immune support — but never FDA-approved in the United States.

Oxytocin

longevity & healthspanBgrade

A naturally occurring nonapeptide — FDA-approved as Pitocin for labor, and separately studied off-label (intranasal) for social bonding and stress research.

SS-31 (Elamipretide)

longevity & healthspanBgrade

A mitochondria-targeting tetrapeptide, FDA-approved in September 2025 for Barth syndrome — a real approval in one narrow rare disease, not a general muscle or longevity drug.

Put the whole protocol
in one place.

Download nowGet Now